Invitae Invitae to Acquire Consumer Health Tech Firm Ciitizen for $325M The company focused on aggregating genomic content in one service believes Ciitizen will enhance its goal by enabling patients to aggregate and share their data to improve healthcare. Jury Awards ArcherDx, MGH $4.7M in Qiagen Patent Infringement Lawsuit A federal jury ruled that various Qiagen sample prep products infringe a pair of US patents underlying ArcherDx's anchored multiplex PCR technology. Invitae Writes off $262.5M Liability Upon Failure to Meet Regulatory Milestone The company still expects the Stratafide cancer test to achieve FDA approval or clearance, but after March 31, 2022. Invitae More Than Doubles Q2 Revenues The company reported $116.3 million in revenues compared to $46.2 million a year ago, which exceeded Wall Street expectations. GenomeWeb Index Gains Slightly in July as Fluidigm, PerkinElmer, Bio-Rad Post Strong Increases The GenomeWeb Index outperformed the Dow Jones, Nasdaq, and Nasdaq Biotechnology Index last month. Jul 15, 2021 Children's National Hospital Wins $12.8M NIH Grant for Pediatric Mendelian Genomics Research Center Jul 2, 2021 Geisinger Trial to Evaluate Chatbot to Boost Cascade Testing in Familial Hypercholesterolemia Premium May 10, 2021 Invitae Sues Natera Alleging Infringement of Patent on DNA Sequencing Assembly Technique May 4, 2021 Invitae Q1 Revenues Increase 61 Percent Apr 14, 2021 Invitae, PCT Therapeutics, Genome Medical Partner to Offer Genetic Testing for Cerebral Palsy Apr 8, 2021 Invitae to Provide Genetic Testing Within eMERGE Population Screening Study Apr 5, 2021 Invitae Acquiring Genosity for $200M; Investment Group Provides Firm $1.15B in Senior Notes Mar 30, 2021 Renal Cell Carcinoma Risk Gene Representation Can Vary With Ancestry Feb 17, 2021 Invitae Q4 2020 Revenues Increase 51 Percent Feb 1, 2021 Oppenheimer Downgrades Invitae to Perform Rating Jan 29, 2021 Invitae, Decibel Therapeutics Launch Free Testing Program for Congenital Hearing Loss Jan 22, 2021 Invitae Prices $400M Common Stock Offering Jan 20, 2021 Invitae to Raise $400M in Proposed Public Offering Jan 14, 2021 Pacific Biosciences CEO Discusses Q4 Results, New Sequencing Platforms at JP Morgan Jan 14, 2021 Invitae, Pharma Firms Partner to Develop Standard MRD Panel for AML Clinical Trials Jan 13, 2021 JP Morgan Healthcare Conference 2021, Day 1: Qiagen, Invitae, Agilent, Sema4, More Jan 13, 2021 Pacific Biosciences, Invitae to Develop Clinical Whole-Genome Sequencing Platform Jan 11, 2021 Invitae 2020 Preliminary Revenues Rise 28 Percent Dec 28, 2020 M&A Deals in MDx/Omics Research Tools Space Fall 13 Percent in 2020 Premium Dec 1, 2020 UnitedHealthcare to Cover NIPT for Average-Risk Pregnancies Load More Breaking News Ancient DNA Analysis Highlights Three Ancestral Populations in Japan FDA Warns of Potential False Positives With Abbott SARS-CoV-2 Molecular Tests New Products Posted to GenomeWeb: Oxford Nanopore, Beckman Coulter, Thermo Fisher Scientific, More People in the News: New Appointments at Sema4, NHGRI, Dante Labs, Ancestry, More Thermo Fisher Scientific Expects 12 Percent Revenue Growth in 2022 In Brief This Week: Myriad Genetics, Danaher, Co-Diagnostics, and More The Scan For Those Thick Tiger Stripes Tigers in India with thick stripes harbor a genetic change, as Gizmodo reports. High GABA Tomatoes The Japan News reports that genome-edited tomatoes with higher GABA levels are now for sale in Japan. Approach for Inclusivity and Diversity A National Human Genome Research Institute team calls for the field to "adopt diversity as an ethos." Science Papers on Tumors Immune System Evasion; Drivers of Genomic Instability, Inflammation In Science this week: study of how tumors evade the adaptive immune system, and more.